The company Horizon Pharma has bought the right for Interferon Gamma in Europe

Horizon Pharma is running a phase-III trial in USA using Interferon gamma and completed the recruitment of 90 patients with Friedreich's ataxia early this month.

They have now announced the agreement with Boehringer Ingelheim International GmbH to buy their rights for this drug in Europe and Middle East.

This is very promising for a future trial and potential use of this drug in Europe if this trial is successful - to read more please visit their newspage here.

Follow Ataxia Ireland on Facebook Follow Ataxia Ireland on Twitter

Text "ATAXIA" to 50300 to donate €4 now! »

People living with an Ataxia benefit enormously from the many services provided by Ataxia Ireland.
Help us to continue helping them

Donate to Ataxia »

Donate to FASILend a helping hand...
Donate to FASI

Ataxia Organsiations »

Click to view European Ataxia OrganisationsClick on the map to access an interactive map for Ataxia organisations worldwide

Follow Ataxia Ireland